Literature DB >> 29923815

Streptococcus and Prevotella are associated with the prognosis of oesophageal squamous cell carcinoma.

Yanfang Liu1, Zheng Lin1,2, Yingying Lin1, Yuanmei Chen3, Xian-E Peng1,2, Fei He1,2, Shuang Liu1, Siyou Yan1, Liping Huang1, Wanting Lu1, Zhisheng Xiang1, Zhijian Hu2,1.   

Abstract

PURPOSE: Oesophageal squamous cell carcinoma (ESCC) is the dominant type of oesophageal cancer among the East Asian population. The role of ESCC tissue bacteria in neoplastic progression has not been fully elucidated. Our goal was to uncover different bacterial communities in pathological staging grouping of ESCC and to identify microorganisms that could predict the likelihood of prognosis.
METHODOLOGY: Tissue samples were obtained from 45 patients and assessed using 16S ribosomal RNA gene sequencing. Significant bacteria were selected to perform survival analysis and evaluate prognostic biomarker.Results/Key findings. We observed variations in the abundance of oesophageal flora among different pathological characteristics of ESCC. Phylum Bacteroidetes, Firmicutes and Spirochaetes showed significantly higher relative abundances among N+ (positive lymph node) patients when compared to N- (negative lymph node) controls, whereas Proteobacteria showed lower abundances in N+ patients. Both genera Prevotella and Treponema were more abundant in the N+ group. In regard to T stage, the abundance of only Streptococcus in T3-4 was significantly higher than that in T1-2, while the other genera showed no significance. On multivariable analysis adjusted for the effects of standard clinicopathological features, combined Streptococcus and Prevotella abundance retained its association with unfavourable survival (hazard ratio, 6.094; 95 % confidence interval, 1.072-34.646; P=0.042), suggesting that this may be an independent prognostic indicator for ESCC.
CONCLUSION: Combined Streptococcus and Prevotella abundance is regarded as an independent species prognostic biomarker in ESCC patients.

Entities:  

Keywords:  16S rRNA; Streptococcus and Prevotella; oesophageal squamous cell carcinoma; prognosis

Mesh:

Substances:

Year:  2018        PMID: 29923815     DOI: 10.1099/jmm.0.000754

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  15 in total

Review 1.  Research progress on gut microbiota in patients with gastric cancer, esophageal cancer, and small intestine cancer.

Authors:  Changchang Chen; Linjie Chen; Lijun Lin; Dazhi Jin; Yaoqiang Du; Jianxin Lyu
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-26       Impact factor: 4.813

Review 2.  Oral Microbiota Variation: A Risk Factor for Development and Poor Prognosis of Esophageal Cancer.

Authors:  Xiaobo Song; Ole K Greiner-Tollersrud; Huimin Zhou
Journal:  Dig Dis Sci       Date:  2021-09-09       Impact factor: 3.487

3.  Characteristics and interplay of esophageal microbiota in esophageal squamous cell carcinoma.

Authors:  Zheng Lin; Wenqing Rao; Zhisheng Xiang; Qiaoyan Zeng; Shuang Liu; Kaili Yu; Jinsong Zhou; Jianwen Wang; Weilin Chen; Yuanmei Chen; Xiane Peng; Zhijian Hu
Journal:  BMC Cancer       Date:  2022-06-24       Impact factor: 4.638

4.  Microbial Characteristics of Locally Advanced Rectal Cancer Patients After Neoadjuvant Chemoradiation Therapy According to Pathologic Response.

Authors:  Qilin Fan; Fumei Shang; Chen Chen; Hongxia Zhou; Jun Fan; Ming Yang; Xiu Nie; Li Liu; Kailin Cai; Hongli Liu
Journal:  Cancer Manag Res       Date:  2021-03-19       Impact factor: 3.989

5.  Microflora composition in the gastrointestinal tract in patients with Barrett's esophagus.

Authors:  Ikenna Okereke; Catherine Hamilton; Gabriel Reep; Timothy Krill; Adam Booth; Yezaz Ghouri; Vikram Jala; Clark Andersen; Richard Pyles
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

6.  Microbiome and oral squamous cell carcinoma: a possible interplay on iron metabolism and its impact on tumor microenvironment.

Authors:  Rodrigo Alex Arthur; Rafael Dos Santos Bezerra; João Paulo Bianchi Ximenez; Bruna Laís Merlin; Raphael de Andrade Morraye; João Valentini Neto; Natália Melo Nasser Fava; David Livingstone Alves Figueiredo; Carlos Alberto Oliveira de Biagi; Maria Jara Montibeller; Jhefferson Barbosa Guimarães; Ellen Gomes Alves; Monique Schreiner; Tiago Silva da Costa; Charlie Felipe Liberati da Silva; Jessica Moraes Malheiros; Luan Henrique Burda da Silva; Guilherme Taborda Ribas; Daisy Obispo Achallma; Camila Margalho Braga; Karen Flaviane Assis Andrade; Valquiria do Carmo Alves Martins; Glauco Vinícius Nestor Dos Santos; Caroline Fabiane Granatto; Ulisses Costa Terin; Igor Henrique Sanches; Diana Estefania Ramos; Humberto Miguel Garay-Malpartida; Gabriela Marcelino Pereira de Souza; Svetoslav Nanev Slavov; Wilson Araújo Silva
Journal:  Braz J Microbiol       Date:  2021-05-18       Impact factor: 2.476

7.  Signatures within esophageal microbiota with progression of esophageal squamous cell carcinoma.

Authors:  Minjuan Li; Dantong Shao; Jiachen Zhou; Jianhua Gu; Junjie Qin; Wen Chen; Wenqiang Wei
Journal:  Chin J Cancer Res       Date:  2020-12-31       Impact factor: 5.087

8.  Microbial Diversity and Composition in Six Different Gastrointestinal Sites among Participants Undergoing Upper Gastrointestinal Endoscopy in Henan, China.

Authors:  Minjuan Li; Dantong Shao; Jiachen Zhou; Jianhua Gu; Junjie Qin; Xinqing Li; Changqing Hao; Wenqiang Wei
Journal:  Microbiol Spectr       Date:  2022-04-25

9.  Association between alcohol consumption and oesophageal microbiota in oesophageal squamous cell carcinoma.

Authors:  Wenqing Rao; Zheng Lin; Shuang Liu; Zhihui Zhang; Qianwen Xie; Huilin Chen; Xi Lin; Yuanmei Chen; Huimin Yang; Kaili Yu; Zhijian Hu
Journal:  BMC Microbiol       Date:  2021-03-06       Impact factor: 3.605

10.  [Microbioma, salud y enfermedad: probióticos, prebióticos y simbióticos].

Authors:  Arley Gómez
Journal:  Biomedica       Date:  2019-12-01       Impact factor: 0.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.